Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12907629
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P.A. Pizzo, D.G. Poplack (eds). Principles and Practice of Pediatric Oncology

  2003cited by this paper
• Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies

  2002cited by this paper
• Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma.

  2002cited by this paper
• Identification of Myc-mediated Death Response Pathways by Microarray Analysis*

  2002cited by this paper
• The impact of chromatin in human cancer: linking DNA methylation to gene silencing.

  2002cited by this paper
• Identification of a Novel Non-structural Maintenance of Chromosomes (SMC) Component of the SMC5-SMC6 Complex Involved in DNA Repair*

  2002cited by this paper
• The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2

  2002cited by this paper
• Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis.

  2002cited by this paper
• Caspr3 and caspr4, two novel members of the caspr family are expressed in the nervous system and interact with PDZ domains.

  2002cited by this paper
• Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.

  2002cited by this paper
• Microarray analysis of E-box binding-related gene expression in young and replicatively senescent human fibroblasts.

  2002cited by this paper
• A Novel c-Myc-responsive Gene, JPO1, Participates in Neoplastic Transformation*

  2001cited by this paper
• Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.

  2001cited by this paper
• Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity.

  2001cited by this paper
• Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors

  2001cited by this paper
• Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism.

  2001cited by this paper
• N‐myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis

  2001influential reference
• Identification and characterization of a novel cell cycle-regulated internal ribosome entry site.

  2000cited by this paper
• Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors

  2000cited by this paper
• MYCN expression in neuroblastoma: A mixed message?

  2000cited by this paper
• The transcriptional signature of dioxin in human hepatoma HepG2 cells.

  2000cited by this paper
• Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis.

  2000cited by this paper
• N-Myc Shares Cellular Functions with c-Myc

  2000cited by this paper
• MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN.

  2000cited by this paper
• Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein.

  2000cited by this paper
• Function of the c-Myc oncogenic transcription factor.

  1999cited by this paper
• Myc-mediated transformation: the repression connection

  1999cited by this paper
• Mapping of the MYCL2 processed gene to Xq22‐23 and identification of an additional L MYC‐related sequence in Xq27.2

  1999cited by this paper
• Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.

  1998cited by this paper
• Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

  1998cited by this paper
• Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

  1998cited by this paper
• Cloning and mapping of the UNC5C gene to human chromosome 4q21-q23.

  1998cited by this paper
• Myc activation reduces fibroblast clonogenicity via an apoptotic mechanism that can be suppressed by a soluble paracrine factor.

  1998cited by this paper
• Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.

  1997cited by this paper
• A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma

  1997cited by this paper
• Modulation of N-myc expression alters the invasiveness of neuroblastoma

  1997cited by this paper
• Targeted expression of MYCN causes neuroblastoma in transgenic mice

  1997cited by this paper
• MYCN protein expression as a predictor of neuroblastoma prognosis.

  1997cited by this paper
• Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.

  1997cited by this paper
• PCTAIRE 2, a Cdc2-related serine/threonine kinase, is predominantly expressed in terminally differentiated neurons.

  1997cited by this paper
• UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins.

  1996cited by this paper
• Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.

  1996cited by this paper
• Modern Applied Statistics with S-Plus.

  1996cited by this paper
• The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma

  1996cited by this paper
• Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family.

  1996cited by this paper
• Identification of a novel conserved human gene, TEGT.

  1995cited by this paper
• Cloning and subcellular localization of novel rab proteins reveals polarized and cell type-specific expression.

  1994cited by this paper
• High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.

  1994cited by this paper
• Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma

  1994cited by this paper
• Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family.

  1994cited by this paper
• Amplification of N-myc as a prognostic marker for patients with neuroblastoma.

  1993cited by this paper
• Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N–myc amplification

  1993cited by this paper
• DNA binding by N- and L-Myc proteins.

  1993cited by this paper
• Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

  1991cited by this paper
• Sequence-specific DNA binding by the c-Myc protein.

  1990influential reference
• myc gene amplification and expression in primary human neuroblastoma.

  1990cited by this paper
• Principles and Practice of Pediatric Oncology

  1989cited by this paper
• N-myc oncogene RNA expression in neuroblastoma.

  1988cited by this paper
• Two human homeobox genes, c1 and c8: structure analysis and expression in embryonic development.

  1987cited by this paper
• Differential and stage-related expression in embryonic tissues of a new human homoeobox gene

  1986cited by this paper
• Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture

  1985cited by this paper
• Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

  1985cited by this paper

• Coexpression of MYCN and ALK Induces Neuroblastoma‐Like Tumors From Human iPS Cell‐Derived Cranial Neural Crest Cells

  2026cites this paper
• 56Fe-ion Exposure Increases the Incidence of Lung and Brain Tumors at a Similar Rate in Male and Female Mice

  2024cites this paper
• 56Fe ion exposure increases the incidence of lung and brain tumors at a similar rate in male and female mice

  2023cites this paper
• Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation

  2023cites this paper
• CASC5 Gene Expression Changes Correlate with Targeted Mutations in Leukemia

  2021cites this paper
• Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming

  2020cites this paper
• Placental expression of FADS1, FADS2, FADS3 desaturases in selected pregnancy pathologies

  2020cites this paper
• TGFBR3L—An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue

  2020cites this paper
• Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

  2019cites this paper
• MiRNA Influences in Neuroblast Modulation: An Introspective Analysis

  2018cites this paper
• The Role of Stromal-Derived Factors in Neuroblastoma Differentiation

  2016cites this paper
• MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells

  2015influential citation
• Downregulation of TrkA protein expression by miRNA‑92a promotes the proliferation and migration of human neuroblastoma cells.

  2014cites this paper
• Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling

  2014cites this paper
• The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential

  2014cites this paper
• Molecular Testing in Paediatric Tumours

  2014cites this paper
• Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma

  2013cites this paper
• Identification of a putative transcriptome signature common to neuroblastoma and neural crest cells

  2013cites this paper
• An extension of the Wilcoxon-Mann-Whitney test for analyzing RT-qPCR data

  2013influential citation
• Neuroblastoma: Role of MYCN/Bmi1 Pathway in Neuroblastoma

  2012cites this paper
• Investigation of system properties related to MYCN oncogene expression in neuroblastoma

  2012cites this paper
• Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma

  2011cites this paper
• Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status

  2011cites this paper
• MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas

  2011cites this paper
• Fatty Acid Desaturase 3 (Fads3) is a singular member of the Fads cluster.

  2011influential citation
• A robust method for estimating gene expression states using Affymetrix microarray probe level data

  2010cites this paper
• Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q

  2010cites this paper
• Cancer esearch cular and Cellular Pathobiology roRNA Mediates DNA Demethylation Events Triggered by R inoic Acid during Neuroblastoma Cell Differentiation

  2010cites this paper
• MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation.

  2010cites this paper
• MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2

  2010cites this paper
• Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha.

  2010cites this paper
• Myc proteins as therapeutic targets

  2010cites this paper
• Global genomic and RNA profiles for novel risk stratification of neuroblastoma

  2010cites this paper
• MYCN oncoprotein targets and their therapeutic potential.

  2010cites this paper
• Tumor and Stem Cell Biology Combinatorial Regulation of Neuroblastoma Tumor Progression by N-Myc and Hypoxia Inducible Factor HIF-1a

  2010cites this paper
• Tumorigenesis and Neoplastic Progression Genes Proximal and Distal to MYCN Are Highly Expressed in Human Neuroblastoma as Visualized by Comparative Expressed Sequence Hybridization

  2010cites this paper
• Heterogeneity of the MYCN Oncogene in Neuroblastoma

  2009influential citation
• Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

  2009cites this paper
• Molecular characterization and classification of neuroblastoma.

  2009influential citation
• Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma

  2009cites this paper
• William L Gerald, M. D., Ph.D., 1954-2008.

  2009cites this paper
• MycN is a transcriptional regulator of livin in neuroblastoma.

  2009cites this paper
• Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation

  2009cites this paper
• High level MycN expression in non-MYCN amplified neuroblastoma is induced by the combination treatment nutlin-3 and doxorubicin and enhances chemosensitivity.

  2009cites this paper
• Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.

  2009cites this paper
• Enteric Neural Crest Differentiation in Ganglioneuromas Implicates Hedgehog Signaling in Peripheral Neuroblastic Tumor Pathogenesis

  2009cites this paper
• Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion.

  2008cites this paper
• Risk Estimation of Neuroblastoma Patients Using Molecular Markers

  2008cites this paper
• Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma

  2008cites this paper
• Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization.

  2008cites this paper
• SHORT REPORT MYCN regulates oncogenic MicroRNAs in neuroblastoma

  2008cites this paper
• MYCN regulates oncogenic MicroRNAs in neuroblastoma

  2007cites this paper
• High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status

  2007cites this paper
• Identification of DEIN, a Novel Gene with High Expression Levels in Stage IVS Neuroblastoma

  2007cites this paper
• Time‐course study of histological and genetic patterns of differentiation in human engineered oral mucosa

  2007cites this paper
• 1H MRS identifies specific metabolite profiles associated with MYCN‐amplified and non‐amplified tumour subtypes of neuroblastoma cell lines

  2007cites this paper
• The RET oncogene is a critical component of transcriptional programs associated with retinoic acid–induced differentiation in neuroblastoma

  2007cites this paper
• Expresión inmunohistoquímica de la proteína mycN y el estado del gen MYCN en tumores neuroblásticos

  2007influential citation
• “Let's try it one more, once”

  2006cites this paper
• Molecularly guided therapy of neuroblastoma: a review of different approaches.

  2006cites this paper
• Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

  2006cites this paper
• Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours

  2006cites this paper
• Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome

  2006cites this paper
• Estudo da expressão de MYCN em neuroblastomas que não o amplifiquem: correlação com estádios e relevância como fator de prognóstico

  2006cites this paper
• Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.

  2006cites this paper
• Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.

  2005cites this paper
• Gene Profiling of High Risk Neuroblastoma

  2005cites this paper
• EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

  2005cites this paper
• High mobility group A1 is a molecular target for MYCN in human neuroblastoma.

  2005cites this paper
• Application of microarray-based technology to neuroblastoma.

  2005cites this paper
• Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.

  2005cites this paper
• Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma.

  2005influential citation
• Genome-wide analysis of gene expression in neuroblastomas detected by mass screening.

  2005cites this paper
• Molecular Pathology of Neuroblastic Tumors Based on Genome-wide Expression Analysis

  2005cites this paper
• Hypoxia and differentiation in human neuroblastoma cells

  2005cites this paper
• Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA.

  2005cites this paper
• Prognostic value of MYCN and ID2 overexpression in neuroblastoma

  2005cites this paper
• MDM2 as a Critical Effector of the MYCN Oncogene in Tumorigenesis

  2005cites this paper
• The impact of MECP2 mutations in the expression patterns of Rett syndrome patients

  2004influential citation
• Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.

  2004influential citation
• Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control

  2004cites this paper
• Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas.

  2004cites this paper
• Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.

  2004cites this paper
• MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.

  2004cites this paper
• Hypoxia and differentiation in human neuroblastoma cells

  year unknowncites this paper